A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IDUs / injection drug users

[Related PubMed/MEDLINE]
Total Number of Papers: 2236
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IDUs  (>> Co-occurring Abbreviation)
Long Form:   injection drug users
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection. HCV, HPgV-2
2019 Full-Genome Analysis of Hepatitis C Virus in Japanese and Non-Japanese Patients Coinfected With HIV-1 in Tokyo. HCV, MSM
2019 Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province. BDs, HCV
2019 High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection. OCI
2019 Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar. HCV
2019 Identification of risk factors for human immunodeficiency virus-1 infection in Khyber Pakhtunkhwa population: A case control study. FCC, HIV-1, HMC, KP
2019 Impact of Mobility on Methicillin-Resistant Staphylococcus aureus among Injection Drug Users. AHRQ, MRSA
2019 Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy. CI, HAART, HIV, IPDs
2019 Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users. bNAb
10  2019 Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users. Abs, HCV, OCI, PBMC, RFLP
11  2019 Prevalence and predictors of self-reported risk behaviors among male injecting drug users. ---
12  2019 Prevalence of Different Genotypes of HIV-1 in Injection Drug Users in China: A Systematic Review and Meta-Analysis. ---
13  2019 Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran. HBV, HCV
14  2019 Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta-Analysis. ---
15  2019 Prioritizing HIV/AIDS prevention strategies in Bandung, Indonesia: A cost analysis of three different HIV/AIDS interventions. HRCMs, IEC, MCHPs, MSM
16  2019 Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia. CI, OR
17  2019 Survival and associated factors among people living with HIV/AIDS: A 30-year national survey in Iran. ART, TB
18  2019 The distinct epidemic characteristics of HCV co-infection among HIV-1-infected population caused by drug injection and sexual transmission in Yunnan, China. HCV, Hgb, HIV, ST
19  2019 [Mortality and influencing factors on injecting drug users with HIV/AIDS in Guizhou province, 1996-2015]. ART, MMT
20  2019 [Prevalence of antiretroviral drug resistance in treatment-naive injecting drug users infected with HIV-1 in Guangzhou, 2008-2015]. nested-PCR, PR, RT
21  2018 A Bayesian evidence synthesis approach to estimate disease prevalence in hard-to-reach populations: hepatitis C in New York City. NYC
22  2018 Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study. HCV, SDs
23  2018 Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region. RFs
24  2018 Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. AOR, CI, HCV, HIV, MSM, RPR
25  2018 Data on hepatitis B, C signs, and HIV-aids among middle-aged and older IDUs in Southwest Iran. FPF, HBV, HCV, TPF
26  2018 Decline and changing profile of hepatitis delta among injection drug users in Spain. Ab, HBsAg
27  2018 Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials. ABSSSI, AEs, PTE
28  2018 Evaluating the care cascade after antiretroviral therapy initiation in Latin America. ART, ART, MSM
29  2018 Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis. APC, GBD, IDU
30  2018 Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users. MDR, TB
31  2018 No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naive HIV Patients. ART, TDR
32  2018 Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis. HBV
33  2018 Prevalence of hepatitis C virus infection among high-risk groups in Iran: a systematic review and meta-analysis. HCV
34  2018 Risk behaviors for sexually transmitted infections in noninjecting drug users: A cross-sectional study. aPR, NIDUs, STIs
35  2018 Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). cART, CI, HIV, HRs, PML
36  2018 Seroepidemiology and phylogenetic analysis of human herpesvirus type 8 in injection drug users and men who have sex with men in northern Taiwan. HHV-8, MSM
37  2018 Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users. DUs
38  2018 The critical role of injecting drug users on the spatial distribution of hepatitis C virus; a study in the West of Iran. HCV
39  2018 The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis. AIDS, HIV
40  2018 Transmission dynamics for Methicilin-resistant Staphalococous areus with injection drug user. AHRQ, MRSA
41  2018 Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis. HAART, PLWH
42  2017 A Clinical Study of Opioid Substitution Therapy in a Tertiary Care Center of Eastern India. OST
43  2017 Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study. HCV
44  2017 An Alarmingly High Proportion of HIV-1 Isolates Carrying Mutations Corresponding to Resistance to Antiretroviral Drugs among HIV-Positive High-Risk Groups in Central Vietnam: a Substudy of the National Sentinel Survey. DRMs, FSWs, MSM
45  2017 An Immunization Strategy for Hidden Populations. MSM, RDS, SWs
46  2017 Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing. CRF, DR, PIs, UDPS
47  2017 Correlates of Knowledge of HIV Transmission Among Incident Cases of HIV in a Cohort of Injection Drug Users Receiving Harm Reduction Services at Karachi, Pakistan. AOR, CI
48  2017 Determinants of HIV positivity among injecting drug users in Delhi and Punjab. HSS
49  2017 Differential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users. ALIVE, CRP, HIV, IL, TNF
50  2017 Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. ---
51  2017 Five Near Full-Length Hepatitis C Virus Sequences Were Identified from HIV Coinfected Injection Drug Users of China. HCV
52  2017 Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. HCV
53  2017 Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. ---
54  2017 Hepatitis C in injection drug users: It is time to treat. DAAs, EASL, HCV, SVR
55  2017 HIV transmission clusters among injecting drug users in Romania. ---
56  2017 Low yield of blood and wound cultures in patients with skin and soft-tissue infections. CIs, MRSA, MSSA, SSTI
57  2017 Mortality Disparities among HIV+ Men and Women in Puerto Rico: Data from the HIV/AIDS Surveillance System 2003-2014. HET, MSM
58  2017 NPS and the methadone queue: Spillages of space and time. ANT, ATS, NPS
59  2017 Phylodynamic Analysis Revealed That Epidemic of CRF07_BC Strain in Men Who Have Sex with Men Drove Its Second Spreading Wave in China. MCC, ML, MSM
60  2017 Prevalence and Clinical Impact of Human Pegivirus-1 Infection in HIV-1-Infected Individuals in Yunnan, China. HIV-1, HPgV-1
61  2017 Revisiting the AIDS Epidemic in Pakistan: Where We Stand and What We Must Aim For. AIDS, HIV-1
62  2017 Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley. SB41
63  2017 Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal. HCV
64  2017 The Importance of Military Conscripts for Surveillance of Human Immunodeficiency Virus Infection and Risk Behavior in Thailand. FSW, FSWs, HIV, MSM, RTA
65  2017 Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. HCV, MMT
66  2017 Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United States. RIC, RR, SES, US, VLs, VS
67  2017 [A cross-sectional survey of receiving no methadone maintenance treatment in HIV infected injecting drug users in Dehong Dai and Jingpo autonomous prefecture, Yunnan province]. MMT
68  2016 Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan. HBsAg, HBV, HIV, OR
69  2016 Bisexual Behavior Among Male Injection Drug Users in New York City. AOR, MSMW
70  2016 Characterization of the Near Full-Length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant in an Injection Drug User from Southern Taiwan. nt, URF
71  2016 Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States. MSM
72  2016 Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biologicalsurvey in Manipur and Nagaland, India. CI, OR, RDS
73  2016 Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC. ---
74  2016 Harm reduction policy in Taiwan: toward a comprehensive understanding of its making and effects. ---
75  2016 Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan. HBsAg, HBV, HDV, HIV
76  2016 HIV and HCV prevalence and incarceration-related risks among injecting drug users in three West Bank governorates. ---
77  2016 HIV incidence and behavioral correlates of HIV acquisition in a cohort of injection drug users in St Petersburg, Russia. HIV
78  2016 HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. CDC, MSM, PrEP
79  2016 HIV/AIDS policy agenda setting in Iran. FSWs, UNGASS
80  2016 HIV/AIDS-related knowledge awareness and risk behaviors among injection drug users in Maanshan, China: a cross-sectional study. HIV, MDCs
81  2016 Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. ---
82  2016 Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons. HCV
83  2016 Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal. ---
84  2016 Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections. HBV, HCV, HIV, PE
85  2016 Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis. DAA, HCV
86  2016 New hepatitis C therapies for special patient populations. DAA, HCV
87  2016 Perceived Severity of and Susceptibility to Overdose Among Injection Drug Users: Relationships With Overdose History. NEPs
88  2016 Pharmacy Intervention to Improve HIV Testing Uptake Using a Comprehensive Health Screening Approach. CI, PR
89  2016 Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada. CI, HIV
90  2016 Subtype distribution of hepatitis C virus in Jiangsu, China. GP, HCV
91  2016 Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients. ART, FePi, TDF
92  2016 The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review. MMT
93  2016 The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California. NEPs
94  2016 Trend Analyses of Users of a Syringe Exchange Program in Philadelphia, Pennsylvania: 1999-2014. SEP
95  2016 [Factors influencing access to methadone maintenance treatment among injecting drug users attending antiretroviral treatment clinics in two counties, Yunnan province]. ART, MMT
96  2016 [Pre-exposure prophylaxis for HIV: clinical practice and challenge]. ART, MSM, PrEP, WHO
97  2016 [Tracing hepatitis C virus transmission by using high-throughput sequencing technique]. HCV
98  2015 A Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users. ARCH
99  2015 A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida. SSTIs
100  2015 Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. aIRR, AIRR, HCV, PO